Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Cube Labs S.p.A. is a prominent player in the life sciences and biotechnology sectors. As an Italian company, it focuses on fostering innovation and development in the healthcare domain. Cube Labs S.p.A. primarily serves as an incubator and accelerator for startups and SMEs in the biotechnology, pharmaceutical, and medical device industries. The company facilitates strategic collaborations and investments, thereby nurturing emerging technologies and innovative solutions that aim to enhance healthcare delivery and patient outcomes. With its headquarters situated in Italy, Cube Labs operates in a strategic location that allows it to tap into a rich ecosystem of research institutions, academic bodies, and industry professionals. The company's efforts in propelling growth and sustainability in life sciences make it a significant player in the market by bridging the gap between groundbreaking research and practical, market-ready healthcare solutions.
The business is unprofitable at the operating level (-37.10% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 28.8% YoY with margins expanding 2.2pp.
Negative free cash flow of -€3M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
€2M
▲ +28.8% YoY
Net Income (TTM)
-€731K
▼ -5.2% YoY
Op. Margin
-37.10%
▲ +2.2pp YoY
ROIC
-1.00%
▼ -0.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-€3M
▲ +31.7% YoY
Op. Cash Flow (TTM)
-€2M
▼ -7.4% YoY
Net Debt
€2M
Cash & Equiv.
€1M
3Y CAGR: +23.8%
Continue Research